Related references
Note: Only part of the references are listed.CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice
JinZhu Ma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants
Mohammed Jubair Hussain et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
Engineering an Effective Immune Adjuvant by Designed Control of Shape and Crystallinity of Aluminum Oxyhydroxide Nanoparticles
Bingbing Sun et al.
ACS NANO (2013)
Responses to multiple injections with alum alone compared to injections with alum adsorbed to proteins in mice
Xuan-Yi Wang et al.
IMMUNOLOGY LETTERS (2013)
Particulate Adjuvant and Innate Immunity: Past Achievements, Present Findings, and Future Prospects
Etsushi Kuroda et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2013)
Coadministration of Polyinosinic: Polycytidylic Acid and Immunostimulatory Complexes Modifies Antigen Processing in Dendritic Cell Subsets and Enhances HIV Gag-Specific T Cell Immunity
Kylie M. Quinn et al.
JOURNAL OF IMMUNOLOGY (2013)
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
Alexandre de Titta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease
Tamiru Negash et al.
VACCINE (2013)
Mechanism of immunopotentiation and safety of aluminum adjuvants
Harm HogenEsch
FRONTIERS IN IMMUNOLOGY (2013)
Antigen depot is not required for alum adjuvanticity
Sharon Hutchison et al.
FASEB JOURNAL (2012)
Targeting tumor antigens to dendritic cells using particulate carriers
Medha D. Joshi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Adjuvants and inactivated polio vaccine: A systematic review
Jennifer Hawken et al.
VACCINE (2012)
The effect of adjuvants on the immune response induced by a DBL4ε-ID4 VAR2CSA based Plasmodium falciparum vaccine against placental malaria
V. V. Pinto et al.
VACCINE (2012)
Macrophagic Myofaciitis a Vaccine (alum) Autoimmune-Related Disease
Eitan Israeli et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)
Getting Closer to the Dirty Little Secret
Karin Pelka et al.
IMMUNITY (2011)
Silica Crystals and Aluminum Salts Regulate the Production of Prostaglandin in Macrophages via NALP3 Inflammasome-Independent Mechanisms
Etsushi Kuroda et al.
IMMUNITY (2011)
An Unexpected Role for Uric Acid as an Inducer of T Helper 2 Cell Immunity to Inhaled Antigens and Inflammatory Mediator of Allergic Asthma
Mirjam Kool et al.
IMMUNITY (2011)
H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
Philippe Moris et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Chitosan Nanoparticles Act as an Adjuvant to Promote both Th1 and Th2 Immune Responses Induced by Ovalbumin in Mice
Zheng-Shun Wen et al.
MARINE DRUGS (2011)
DNA released from dying host cells mediates aluminum adjuvant activity
Thomas Marichal et al.
NATURE MEDICINE (2011)
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
Tracy L. Flach et al.
NATURE MEDICINE (2011)
Evaluation of the intramuscular administration of Cervarix (TM) vaccine on fertility, pre- and post-natal development in rats
Lawrence Segal et al.
REPRODUCTIVE TOXICOLOGY (2011)
New adjuvants for human vaccines
M. Lamine Mbow et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
The immunobiology of aluminium adjuvants: how do they really work?
Christopher Exley et al.
TRENDS IN IMMUNOLOGY (2010)
Mechanism of action of clinically approved adjuvants
Bart N. Lambrecht et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Characterization of the freeze sensitivity of a hepatitis B vaccine
Dexiang Chen et al.
HUMAN VACCINES (2009)
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2009)
A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome
Christopher Exley et al.
MEDICAL HYPOTHESES (2009)
MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
Angelika Banzhoff et al.
PLOS ONE (2009)
Mechanism of action of licensed vaccine adjuvants
Elaine Tritto et al.
VACCINE (2009)
Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants
LaToya Jones Braun et al.
VACCINE (2009)
Towards an understanding of the adjuvant action of aluminium
Philippa Marrack et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients
Jiri Beran
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention
Tino F. Schwarz
EXPERT REVIEW OF VACCINES (2008)
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Mirjam Kool et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome
Mirjam Kool et al.
JOURNAL OF IMMUNOLOGY (2008)
Influence of Particle Size and Antigen Binding on Effectiveness of Aluminum Salt Adjuvants in a Model Lysozyme Vaccine
Amber Clausi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Stephanie C. Eisenbarth et al.
NATURE (2008)
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
Andreas Wack et al.
VACCINE (2008)
Cross-protection by MF59™-adjuvanted influenza vaccine:: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
Filippo Ansaldi et al.
VACCINE (2008)
Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation
Stanley L. Hem et al.
EXPERT REVIEW OF VACCINES (2007)
Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response
Bethany Hansen et al.
VACCINE (2007)
Freezing temperatures in the vaccine cold chain: A systematic literature review
Dipika M. Matthias et al.
VACCINE (2007)
Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release
Hanfen Li et al.
JOURNAL OF IMMUNOLOGY (2007)
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling
Amanda L. Gavin et al.
SCIENCE (2006)
Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene
Giuseppe Del Giudice et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine
G Del Giudice et al.
VACCINE (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice
AA Shvedova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
In vitro toxicity of nanoparticles in BRL 3A rat liver cells
SM Hussain et al.
TOXICOLOGY IN VITRO (2005)
Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants
I Berthold et al.
VACCINE (2005)
Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid
GL Morefield et al.
VACCINE (2005)
Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents
H Theeten et al.
VACCINE (2005)
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type
AC Rimaniol et al.
VACCINE (2004)
Promotion of B cell immune responses via an alum-induced myeloid cell population
MB Jordan et al.
SCIENCE (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants
S Jendrek et al.
VACCINE (2003)
Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production
S Iyer et al.
VACCINE (2003)
Aluminum inclusion macrophagic myofasciitis: a recently identified condition
RK Gherardi et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2003)
Measuring the surface area of aluminum hydroxide adjuvant
CT Johnston et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
The role of the adsorption process for production and control combined adsorbed vaccines
W Matheis et al.
VACCINE (2001)
Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines
Y Shi et al.
VACCINE (2001)
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle
RK Gherardi et al.
BRAIN (2001)
Storage at -3°C for 24 h alters the immunogenicity of pertussis vaccines
CA Boros et al.
VACCINE (2001)
Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits
MF Chang et al.
VACCINE (2001)
Adjuvants designed for veterinary and human vaccines
J Aucouturier et al.
VACCINE (2001)
Detoxification of endotoxin by aluminum hydroxide adjuvant
Y Shi et al.
VACCINE (2001)
Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
R Gasparini et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2001)
Share Paper
